Works matching DE "TUMOR markers"

Results: 5000
    1

    Trial Watch.

    Published in:
    OncoImmunology, 2014, v. 3, n. 4, p. N.PAG, doi. 10.4161/onci.28185
    By:
    • Pol, Jonathan;
    • Bloy, Norma;
    • Obrist, Florine;
    • Eggermont, Alexander;
    • Galon, Jérôme;
    • Hervé Fridman, Wolf;
    • Cremer, Isabelle;
    • Zitvogel, Laurence;
    • Kroemer, Guido;
    • Galluzzi, Lorenzo
    Publication type:
    Article
    2
    3
    4

    Phase I clinical trial combining imatinib mesylate and IL-2: HLA-DR<sup>+</sup> NK cell levels correlate with disease outcome.

    Published in:
    OncoImmunology, 2013, v. 2, n. 2, p. e23080-1, doi. 10.4161/onci.23080
    By:
    • Chaput, Nathalie;
    • Flament, Caroline;
    • Locher, Clara;
    • Desbois, Mélanie;
    • Rey, Annie;
    • Rusakiewicz, Sylvie;
    • Poirier-Colame, Vichnou;
    • Pautier, Patricia;
    • Le Cesne, Axel;
    • Soria, Jean-Charles;
    • Paci, Angelo;
    • Rosenzwajg, Michelle;
    • Klatzmann, David;
    • Eggermont, Alexander;
    • Robert, Caroline;
    • Zitvogel, Laurence
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Tissue elasticity properties as biomarkers for prostate cancer.

    Published in:
    Cancer Biomarkers, 2008, v. 4, n. 4/5, p. 213, doi. 10.3233/CBM-2008-44-505
    By:
    • Hoyt, Kenneth;
    • Castaneda, Benjamin;
    • Zhang, Man;
    • Nigwekar, Priya;
    • di Sant'Agnese, P. Anthony;
    • Joseph, Jean V.;
    • Strang, John;
    • Rubens, Deborah J.;
    • Parker, Kevin J.
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Heterogeneity of predictive biomarker expression in gastric and esophago-gastric junction carcinoma with peritoneal dissemination.

    Published in:
    Gastric Cancer, 2025, v. 28, n. 4, p. 569, doi. 10.1007/s10120-025-01609-7
    By:
    • Angerilli, Valentina;
    • Callegarin, Matilde;
    • Govoni, Ilaria;
    • De Lisi, Giuseppe;
    • Paudice, Michele;
    • Fugazzola, Paola;
    • Vanoli, Alessandro;
    • Parente, Paola;
    • Bergamo, Francesca;
    • Luchini, Claudio;
    • Dei Tos, Angelo Paolo;
    • Grillo, Federica;
    • Lonardi, Sara;
    • Mastracci, Luca;
    • Spolverato, Gaya;
    • Fassan, Matteo
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Prognostic Nutrition Index as a Biomarker for Treatment Sensitivity to Chemotherapy and Nivolumab as the First-Line Treatment in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.

    Published in:
    Oncology, 2025, v. 103, n. 6, p. 469, doi. 10.1159/000541544
    By:
    • Nakazawa, Nobuhiro;
    • Sano, Akihiko;
    • Kumakura, Yuji;
    • Yamashita, Toshiki;
    • Tanaka, Naritaka;
    • Saito, Kana;
    • Kimura, Akiharu;
    • Kasuga, Kengo;
    • Nakazato, Kenji;
    • Yoshinari, Daisuke;
    • Shimizu, Hisashi;
    • Ubukata, Yasunari;
    • Hosaka, Hisashi;
    • Shiraishi, Takuya;
    • Sakai, Makoto;
    • Sohda, Makoto;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Article
    47

    Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma.

    Published in:
    Oncology, 2025, v. 103, n. 6, p. 490, doi. 10.1159/000541250
    By:
    • LaPelusa, Michael;
    • Chamseddine, Shadi;
    • Tran Cao, Hop Sanderson;
    • Xiao, Lianchun;
    • Hasanov, Elshad;
    • Bhosale, Priya;
    • Amin, Hesham M.;
    • Mohamed, Yehia I.;
    • Gok Yavuz, Betul;
    • Sakr, Yara;
    • Xu, Li;
    • Hu, Ian;
    • Lee, Sunyoung S.;
    • Sakamuri, Divya;
    • Jindal, Sonali;
    • Nguyen, Van;
    • Curran, Michael A.;
    • Sun, Ryan;
    • Rashid, Asif;
    • Duda, Dan Gabriel
    Publication type:
    Article
    48
    49
    50